Mesa, Ariz. – October 07, 2026 -- Bright Path, a U.S. pharmaceutical manufacturer, has been named a 2026 AZBio Fast Lane Award honoree by the Arizona Bioindustry Association, recognizing milestones reached over the past 18 months including a first-of-its-kind FDA manufacturing designation and committed commercial production of hospital medicines facing chronic shortages. The company was honored at the 23rd Annual AZBio Awards at the Phoenix Convention Center during Arizona Bioscience Week.

Boston – – September 25, 2026 -- MagLev Aero has secured concurrent contracts from the Defense Advanced Research Projects Agency under its Minimum Viable Product (MVP) and Embedded Entrepreneur Initiative (EEI) programs, providing non-dilutive funding to push its propulsion platform to Technology Readiness Level 6 (TRL-6).